HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya

AIDS

Volumn 17, Issue 4, 2003, Pages 595-603

  Van Eijk, Anna M ^a,b,e   Ayisi, John G ^a,b   Ter Kuile, Feiko O ^a,b   Misore, Ambrose O ^c   Otieno, Juliana A ^c   Rosen, Daniel H ^d   Kager, Piet A ^b   Steketee, Richard W ^d   Nahlen, Bernard L ^d  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MINISTRY OF HEALTH   (Kenya)

^d NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^e NONE   (Kenya)

Author keywords

Africa; HIV infection; Malaria; Pregnancy; Women

Indexed keywords

ADULT; AGE; ARTICLE; BLOOD SMEAR; CONTROLLED STUDY; FEMALE; FEVER; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MAJOR CLINICAL STUDY; MALARIA; MOTHER; PARASITEMIA; PIGMENTATION; PLACENTA; PREGNANCY; PREVALENCE; PRIMIGRAVIDA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

FEMALE; GRAVIDITY; HIV SEROPOSITIVITY; HUMANS; INFANT, NEWBORN; MALARIA, FALCIPARUM; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY TRIMESTER, THIRD; PREVALENCE; RISK ASSESSMENT;

EID: 0037423825     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200303070-00015     Document Type: Article

References (22)

1. United Nations Children's Fund. The state of the world's children. New York: Oxford University Press; 1998.
2. Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull WHO 1983; 61:1005-1016.
3. Menendez C. Malaria during pregnancy: a priority area of malaria research and control. Parasitol Today 1995; 11:178-183.
4. McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985; 312:82-90.
5. Kramer MS. Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ 1987; 65:663-737.
6. Steketee RW, Wirima JJ, Bloland PB, Chilima B, Mermin JH, Chitsulo L, Breman JG. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 1996; 55 (1 Suppl.):42-49.
7. Verhoeff FH, Brabin BJ, Hart CA, Chimsuku L, Kazembe P, Broadhead RL. Increased prevalence of malaria in HIV-infected pregnant women and its implication for malaria control. Trop Med Int Health 1999; 4:5-12.
8. Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, et al. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 1998; 59:813-822.
9. Van Eijk AM, Ayisi JG, Ter Kuile FO, Misore A, Otieno JA, Kolczak MS, et al. Human immunodeficiency virus seropositivity and malaria as risk factors for third-trimester anemia in asymptomatic pregnant women in western Kenya. Am J Trop Med Hyg 2001; 65:623-630.
10. Bloland PB, Lackritz EM, Kazembe PN, Were JB, Steketee R, Campbell CC. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis 1993; 167:932-937.
11. Kenya Ministry of Health. Kenya national policy document for malaria control. Nairobi: Ministry of Health; 1997.
12. Bulmer JN, Rasheed FN, Morrison L, Francis N, Greenwood BM. Placental malaria II. A semi-quantitative investigation of the pathological features. Histopathology 1993; 22:219-225.
13. Ryder RW, Nsa W, Hassig SE, Behets F, Rayfield M, Ekungola B, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med 1989; 320:1637-1642.
14. Hennekens CH, Buring JE. Measures of disease frequency. In: Epidemiology in medicine. 1st ed. Mayrent SL (editor). Boston/Toronto: Little, Brown and Company; 1987. pp. 87-96.
15. Fried M, Nosten F, Brockman A, Brabin BJ, Duffy PE. Maternal antibodies block malaria. Nature 1998; 395:851-852.
16. Rasheed FN, Bulmer JN, Dunn DT, et al. Suppressed peripheral and placental blood lymphoproliferative responses in first pregnancies: relevance to malaria. Am J Trop Med Hyg 1993; 48:154-160.
17. Vleugels MP, Eling WM, Rolland R, de Graaf R. Cortisol levels in human pregnancy in relation to parity and age. Am J Obstet Gynecol 1986; 155:118-121.
18. Moore JM, Nahlen BL, Misore A, Lal AA, Udhyakumar V. Immunity to placental malaria. I. Elevated production of interferon-gamma by placental blood mononuclear cells is associated with protection in an area with high transmission of malaria. J Infect Dis 1999; 179:1218-1225.
19. Moore JM, Ayisi J, Nahlen BL, Misore A, Lal AA, Udhayakumar V. Immunity to placental malaria II. Placental antigen-specific cytokine responses are impaired in human immunodeficiency virus-infected women. J Infect Dis 2000; 182:960-964.
20. Whitworth J, Morgan D, Quigley M, Smith A, Mayanja B, Eotu H, et al. Effect of HIV-1 and increasing immunosuppression on malaria and clinical episodes in adults in rural Uganda: a cohort study. Lancet 2000; 356:1051-1056.
21. National Council for Population and Development, Central Bureau of Statistics (Office of the Vice President and Ministry of Planning and National Development, Kenya) and Macro International Inc. Kenya demographic and health survey 1998. Maryland, USA: Calverton, 1999.
22. Miotti PG, Liomba G, Dallabetta GA, Hoover DR, Chiphangwi JD, Saah AJ. T lymphocyte subsets during and after pregnancy: analysis in human immunodeficiency virus type 1-infected and -uninfected Malawian mothers. J Infect Dis 1992; 165:1116-1119.